Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05593328 |
|---|---|
| Brief Title: | Study of Onvansertib in Combination With FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Participants With a Kirsten Rat Sarcoma Virus Gene (KRAS) or Neuroblastoma-RAS (NRAS) Mutation |
| First Submitted : | October 20, 2022 |
| First Submitted that Met QC Criteria : | October 20, 2022 |
| First Posted : | October 25, 2022 |
| Last Update Submitted that Met QC Criteria : | January 16, 2024 |
| Last Update Posted : | January 17, 2024 |